Lazard Asset Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Sell |
|
|||||
|
2025
Q1 | $1.12M | Sell |
|
|||||
|
2024
Q4 | $2.06M | Buy |
|
|||||
|
2024
Q3 | $428K | Sell |
|
|||||
|
2024
Q2 | $568K | Buy |
|
|||||
|
2024
Q1 | $188K | Buy |
|
|||||
|
2023
Q4 | $47K | Sell |
|
|||||
|
2023
Q3 | $120K | Buy |
|
|||||
|
2023
Q2 | $175K | Buy |
|
|||||
|
2023
Q1 | $63K | Sell |
|
|||||
|
2022
Q4 | $94K | Buy |
|
|||||
|
2022
Q3 | $57K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $939K | Buy |
|
|||||
|
2021
Q4 | $77K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $11K | Sell |
|
|||||
|
2021
Q1 | $152K | Sell |
|
|||||
|
2020
Q4 | $612K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $70K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $11K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $300K | Sell |
|
|||||
|
2015
Q3 | $414K | Buy |
|